Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

SOP for Tablet Compression Operation and In-Process Controls

Posted on November 25, 2025November 25, 2025 By digi


SOP for Tablet Compression Operation and In-Process Controls

Comprehensive SOP for Tablet Compression Operation and In-Process Controls

Tablet compression represents a critical stage in pharmaceutical solid dosage form manufacturing, demanding rigorous control to ensure product quality, efficacy, and patient safety. Implementing a robust tablet compression SOP benefits production, QA, and QC teams by standardizing procedures, reducing variability, and facilitating compliance with regulatory mandates from agencies such as the FDA, EMA, and MHRA.

This step-by-step tutorial guide provides a detailed approach to setting up, operating, and monitoring tablet compression machines, with a focus on essential in-process controls including tablet hardness, weight variation, and key compression parameters. The guidance applies across jurisdictions covered by FDA 21 CFR, EU GMP Volume 4, PIC/S PE 009, and WHO GMP frameworks, ensuring a harmonized compliance strategy.

Step 1: Preparation and Pre-Operational Verification

Prior to initiating the tablet compression cycle, thorough preparations and verifications are mandatory to guarantee machine readiness and environmental compliance.

Machine Cleaning and Setup

  • Ensure the tablet compression machine has undergone validated cleaning procedures compliant with GMP guidelines to prevent cross-contamination. Document all cleaning activities.
  • Verify that all tooling (dies, punches) are appropriate for the batch and have been inspected for wear or damage.
  • Install the tooling correctly, securing punches and dies as per manufacturer and SOP instructions.

Environmental and Utility Checks

  • Confirm that the compression room environment meets GMP-controlled conditions (temperature, humidity, and air cleanliness per Annex 1 EU GMP standards).
  • Ensure adequate utilities including compressed air, vacuum, and power supply are stable and within specified ranges.

Documentation and Batch Record Preparation

  • Review the batch manufacturing record (BMR) or batch production record (BPR) for completeness and confirmation of raw material quantities.
  • Prepare logs for in-process controls highlighting parameters such as tablet hardness and weight variation to be recorded.
Also Read:  Template: Change Control SOP and Forms for Pharma Manufacturing Sites

Calibration and Instrument Verification

  • Check calibration status of all critical measuring instruments (tablet hardness testers, weight scales, thickness gauges) used during the compression process. Instruments must be within calibration period in accordance with Annex 15 of EU GMP.
  • Carry out functional checks to verify instrument performance prior to batch start.

These preparatory steps form the foundation of a compliant tablet compression SOP. They mitigate risks of product defects and regulatory non-conformances.

Step 2: Tablet Compression Machine Setup and Optimization

Once preparations are complete, the next phase involves machine startup and optimization of compression parameters. The goal is to establish controlled, reproducible tablet characteristics throughout the batch.

Feeding and Die Filling Adjustment

  • Set granule feeding rate to ensure consistent and uniform die filling — critical to control weight variation of tablets.
  • Adjust the hopper agitation and feeder paddle speed to avoid segregation or capping of feed material.
  • Confirm die filling visually if possible, or via trial runs.

Setting Compression Force and Speed

  • Adjust the compression force based on prior tablet formulation development and target tablet hardness specifications.
  • Set machine speed within validated limits balancing productivity and product integrity.
  • Ensure uniform pressure distribution between punches to prevent tablet defects such as lamination or capping.

Synchronization of Upper and Lower Punches

  • Calibrate the relative position of upper and lower punches to achieve the desired tablet thickness and density.
  • Monitor press dwell time and maximum compression force to optimize tablet hardness and dissolution characteristics.

Trial Compression Run

  • Conduct a short trial run on the machine using the defined compression parameters.
  • Collect initial tablets for evaluation of weight, hardness, thickness, and appearance.
  • Make necessary adjustments to compression force, feed frame speed, or punches alignment to meet specifications prior to full-scale production.
Also Read:  Template: SOP for GMP Document and Record Control

Document all settings and observations in the batch record. This step is crucial for ensuring the compression parameters are within validated ranges, as required under GMP and by the FDA’s process validation guidelines.

Step 3: In-Process Controls During Tablet Compression

During tablet compression, continuous and periodic in-process monitoring preserves manufacturing precision and product quality, supporting real-time decision-making.

Tablet Weight Variation Monitoring

  • Collect tablets at fixed intervals (e.g., every 30 minutes or 10,000 tablets) and individually weigh a pre-defined sample size (typically 20 tablets).
  • Calculate mean weight, individual deviations, and compare against established limits (usually ±5% per pharmacopeial standards).
  • If deviation exceeds limits, pause production and investigate cause—feed material consistency, machine settings, or tooling wear.

Tablet Hardness Testing

  • Measure the crushing strength (tablet hardness) using calibrated hardness testers on samples taken at regular intervals to ensure tablets have appropriate mechanical strength.
  • Compare results with product specifications to detect unacceptable variations which could compromise drug release or handling.
  • Monitor trends and intervene if hardness drifts outside acceptable ranges by adjusting compression force or speed.

Tablet Thickness and Visual Inspection

  • Measure tablet thickness to verify dimensional consistency; deviations may indicate punch misalignment or wear requiring corrective action.
  • Perform visual inspection for physical defects such as cracks, chips, capping, or lamination.
  • Maintain records of these observations as part of routine in-process quality checks.

Compression Parameter and Machine Data Logging

  • Record machine parameters including compression force, turret speed, and punch position continuously or at defined intervals.
  • Utilize machine data to identify anomalies, potential equipment malfunction, and to support ongoing process validation.

Such rigorous in-process controls reconcile operational efficiency with regulatory requirements, ensuring batch-to-batch consistency compliant with FDA drug manufacturing guidance and EU GMP Volume 4 expectations.

Step 4: Post-Compression Activities and Documentation

Completion of tablet compression is followed by systematic shutdown, cleaning, and thorough documentation activities critical for GMP compliance and traceability.

Machine Shutdown and Cleaning

  • Stop machine operations following SOP-defined procedures ensuring no tablets remain compressed when halted.
  • Disassemble tooling components and thoroughly clean all contact parts to prevent cross-contamination in line with cleaning validation protocols.
  • Dispose of or quarantine rejected or non-conforming tablets as per QA directives.
Also Read:  SOP for Control and Storage of Printed Packaging Materials

Batch Record Completion

  • Complete all in-process records including tablet weight variation, hardness, thickness, compression parameters, and any deviations encountered.
  • Verify signatures and dates by authorized personnel to uphold accountability and GMP record integrity.

Equipment Maintenance and Calibration Scheduling

  • Schedule routine maintenance post batch to mitigate any wear or faults affecting subsequent production runs.
  • Plan calibration for instruments if needed, based on usage or trending data suggesting drift.

Quality Control Sample Submission

  • Submit representative samples to QC laboratories for final release testing, including assay, dissolution, and uniformity checks.
  • Ensure chain-of-custody and sample handling comply with GMP documentation and storage requirements.

These concluding steps ensure that the tablet compression SOP supports not only robust operation but also comprehensive GMP-compliant documentation and equipment stewardship. This aligns with the principles articulated in ICH Q7 and PIC/S guidance for manufacturing controls.

Conclusion: Integrating the Tablet Compression SOP into Quality Systems

The described step-by-step approach to a tablet compression SOP integrates technical precision, process control, and regulatory compliance. It enables production teams to operate pharmaceutical compression machines with optimized compression parameters and controls focused on critical quality attributes such as tablet hardness and weight variation.

Compliance with international GMP frameworks, including FDA 21 CFR and EU GMP, not only ensures regulatory acceptance across the US, UK, and EU but also guarantees consistent production of high-quality tablets. Implementation of thorough in-process checks bridged with robust documentation facilitates both routine manufacturing cycles and inspection readiness.

Pharmaceutical manufacturers adopting these standards strengthen their overall quality system and risk management efforts, ultimately enhancing patient safety and therapeutic efficacy. For further detailed regulatory guidance, refer to official documents such as the ICH Quality Guidelines.

Compression & Encapsulation Tags:hardness, ipc, pharmasop, sop, tablet compression, weight

Post navigation

Previous Post: SOP for Capsule Filling Operation and In-Process Checks
Next Post: SOP for Blending and Blend Uniformity Checks in Tablet Production

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme